NO20082497L - Diarylureaer for behandling av pulmonal hypertensjon - Google Patents

Diarylureaer for behandling av pulmonal hypertensjon

Info

Publication number
NO20082497L
NO20082497L NO20082497A NO20082497A NO20082497L NO 20082497 L NO20082497 L NO 20082497L NO 20082497 A NO20082497 A NO 20082497A NO 20082497 A NO20082497 A NO 20082497A NO 20082497 L NO20082497 L NO 20082497L
Authority
NO
Norway
Prior art keywords
treatment
pulmonary hypertension
diarylureas
diarylurea compound
diarylurea
Prior art date
Application number
NO20082497A
Other languages
English (en)
Inventor
Bernd Riedl
Peter Sandner
Hanna Tinel
Joachim Hutter
Martina Klein
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of NO20082497L publication Critical patent/NO20082497L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Det er beskrevet fannasøytiske preparater for behandling, forebyggelse eller kontroll av pulmonal hypertensjon omfattende minst en diarylureaforbindelse eventuelt kombinert med minst ett ytterligere terapeutisk middel. Nyttige kombinasjoner omfatter for eksempel BAY 43-9006 som en diarylureaforbindelse.
NO20082497A 2005-11-10 2008-06-03 Diarylureaer for behandling av pulmonal hypertensjon NO20082497L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05024508 2005-11-10
EP05027449 2005-12-15
EP06007775 2006-04-13
PCT/EP2006/010405 WO2007054215A1 (en) 2005-11-10 2006-10-30 Diaryl ureas for treating pulmonary hypertension

Publications (1)

Publication Number Publication Date
NO20082497L true NO20082497L (no) 2008-06-03

Family

ID=37651281

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082497A NO20082497L (no) 2005-11-10 2008-06-03 Diarylureaer for behandling av pulmonal hypertensjon

Country Status (23)

Country Link
US (1) US20090176791A1 (no)
EP (1) EP1948176B1 (no)
JP (1) JP5075832B2 (no)
KR (1) KR20080066030A (no)
AR (1) AR057848A1 (no)
AT (1) ATE493986T1 (no)
AU (1) AU2006312713A1 (no)
BR (1) BRPI0618524A2 (no)
CA (1) CA2628847A1 (no)
CU (1) CU23815A3 (no)
DE (1) DE602006019468D1 (no)
DK (1) DK1948176T3 (no)
EC (1) ECSP088429A (no)
IL (1) IL191010A0 (no)
MY (1) MY144860A (no)
NO (1) NO20082497L (no)
NZ (1) NZ568031A (no)
PL (1) PL1948176T3 (no)
PT (1) PT1948176E (no)
SV (1) SV2009002899A (no)
TW (1) TW200735869A (no)
UY (1) UY29902A1 (no)
WO (1) WO2007054215A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
CA2359244C (en) 1999-01-13 2013-10-08 Bayer Healthcare Llc .omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
EP2324825A1 (en) 2002-02-11 2011-05-25 Bayer Healthcare LLC Aryl ureas with angiogenesis inhibiting activity
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
DE602004007382T2 (de) * 2003-05-20 2008-04-17 Bayer Pharmaceuticals Corp., West Haven Diaryl-harnstoffe für durch pdgfr vermittelte krankheiten
DK1663978T3 (da) 2003-07-23 2008-04-07 Bayer Pharmaceuticals Corp Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
KR101335932B1 (ko) 2005-03-07 2013-12-04 바이엘 헬스케어 엘엘씨 암의 치료를 위한 오메가-카르복시아릴 치환된 디페닐우레아를 포함하는 제약 조성물
WO2007087575A2 (en) * 2006-01-24 2007-08-02 University Of Chicago Compositions and methods for treating pulmonary hypertension
AR062927A1 (es) * 2006-10-11 2008-12-17 Bayer Healthcare Ag 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
WO2008089389A2 (en) 2007-01-19 2008-07-24 Bayer Healthcare Llc Treatment of cancers with acquired resistance to kit inhibitors
WO2009156070A1 (en) * 2008-06-25 2009-12-30 Bayer Schering Pharma Aktiengesellschaft Diaryl urea for treating heart failure
EP2621486A1 (en) 2010-10-01 2013-08-07 Bayer Intellectual Property GmbH Substituted n-(2-arylamino)aryl sulfonamide-containing combinations
MY157429A (en) 2011-06-24 2016-06-15 Amgen Inc Trpm8 antagonists and their use in treatments
JP2014517074A (ja) 2011-06-24 2014-07-17 アムジエン・インコーポレーテツド Ｔｒｐｍ８アンタゴニストおよび治療におけるそれらの使用
US8586527B2 (en) * 2011-10-20 2013-11-19 Jaipal Singh Cerivastatin to treat pulmonary disorders
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
CN109568319A (zh) 2013-01-10 2019-04-05 普尔莫凯恩股份有限公司 非选择性激酶抑制剂
WO2015054574A1 (en) 2013-10-11 2015-04-16 Zisman Lawrence S Spray dry formulations
EP3082428A4 (en) 2013-12-09 2017-08-02 Respira Therapeutics, Inc. Pde5 inhibitor powder formulations and methods relating thereto
US11057446B2 (en) 2015-05-14 2021-07-06 Bright Data Ltd. System and method for streaming content from multiple servers
CN110087653A (zh) 2016-10-27 2019-08-02 普尔莫凯恩股份有限公司 用于治疗肺高血压的组合疗法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7928239B2 (en) * 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
US20020065296A1 (en) * 1999-01-13 2002-05-30 Bayer Corporation Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
EP2324825A1 (en) * 2002-02-11 2011-05-25 Bayer Healthcare LLC Aryl ureas with angiogenesis inhibiting activity
DE602004007382T2 (de) * 2003-05-20 2008-04-17 Bayer Pharmaceuticals Corp., West Haven Diaryl-harnstoffe für durch pdgfr vermittelte krankheiten

Also Published As

Publication number Publication date
PL1948176T3 (pl) 2011-05-31
PT1948176E (pt) 2011-03-07
JP5075832B2 (ja) 2012-11-21
ATE493986T1 (de) 2011-01-15
EP1948176A1 (en) 2008-07-30
MY144860A (en) 2011-11-30
TW200735869A (en) 2007-10-01
BRPI0618524A2 (pt) 2011-09-06
CA2628847A1 (en) 2007-05-18
UY29902A1 (es) 2007-06-29
JP2009514909A (ja) 2009-04-09
CU20080082A7 (es) 2011-07-11
AU2006312713A1 (en) 2007-05-18
WO2007054215A1 (en) 2007-05-18
NZ568031A (en) 2011-06-30
US20090176791A1 (en) 2009-07-09
AR057848A1 (es) 2007-12-19
CU23815A3 (es) 2012-06-21
DK1948176T3 (da) 2011-04-18
EP1948176B1 (en) 2011-01-05
ECSP088429A (es) 2008-07-30
SV2009002899A (es) 2009-04-28
DE602006019468D1 (de) 2011-02-17
IL191010A0 (en) 2009-08-03
KR20080066030A (ko) 2008-07-15

Similar Documents

Publication Publication Date Title
CU23815A3 (es) Diarilureas para el tratamiento de hipertensión pulmonar
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
NO20080622L (no) Disykloalkylurea-glukokinase aktivatorer
WO2008131000A3 (en) 7-substituted indole mcl-1 inhibitors
NO20052626D0 (no) Middel for forhindring eller behandling av neuropati
NO20081042L (no) PPAR aktive forbindelser
WO2006110816A3 (en) 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
WO2007126957A3 (en) New compounds
WO2009042114A3 (en) Phenazine derivatives and uses thereof
DK1984357T3 (da) 2,4-pyrimidindiaminforbindelser til behandling eller forebyggelse af autoimmunsygdomme
NO20083923L (no) Pyrazolkinoloner er potente parp-inhibitorer
NO20092711L (no) Metoder for anvendelse av cyclopaminanaloger
NO20072352L (no) Forbindelser og sammensetninger som inhibitorer av cannabinoidreceptor 1-aktivitet
CL2008003691A1 (es) Compuestos derivados de 4-(fenil o piridin) pirimidina, inhibidores de la elastasa neutrofila humana; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento y/o la prevencion de hipertension arterial pulmonar, epoc, enfisema pulmonar, entre otras.
NO20072608L (no) Biaryloksymetylarenkarboksylsyrer
NO20070855L (no) Arylidener for behandling av estrogenrelaterte reseptor-alfamedierte sykdommer.
NO20072963L (no) 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere
DK2209778T3 (da) Pyridin-2-yl-amino-1, 2, 4-thiadiazolderivater som glucokinase-aktivatorer til behandling af diabetes mellitus
NO20090764L (no) 4-hydroksytiobenzamidderivater og legemidler
UY29616A1 (es) Compuestos químicos iii
UY29615A1 (es) Compuestos quimicos iv
NO20091353L (no) Serine hydrolaseinhibitorer
ATE464307T1 (de) Mif-hemmer
WO2008008700A3 (en) Substituted cyclopentane derivatives as therapeutic agents
WO2008048121A3 (en) Macrocyclic cysteine protease inhibitors and compositions thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application